Patent Landscape Report on Ritonavir - WIPO

More documents

Recommendations

Info

Thomson InnovationCollection: US Grant,US App,WO App,EPSearch QueryCTB=(((antiviral* or protease ADJ inhibitor* or ant*retroviral*) and (CYP3A4 or cytochromeADJ p?450)) and (thiazo*)) AND DP>=(20050101);CTB=(((antiviral* or protease ADJ inhibitor* or ant*retroviral*) and (thiazo*) and (peptid*)))AND DP>=(20050101);CTB=(((antiviral* or protease ADJ inhibitor* or ant*retroviral*) and (thiazo*) and (peptid*) and(HIV OR AIDS or retroviral or anti*retroviral* or immunodefic*))) AND DP>=(20050101);CTB=(((antiviral* or protease ADJ inhibitor* or ant*retroviral*) and (thiazo* or heterocycl*)and (peptid*) and (HIV OR AIDS or retroviral or anti*retroviral* or immunodefic*))) ANDDP>=(20050101);CL=(((antiviral* or protease ADJ inhibitor* or ant*retroviral*) and (thiazo* or heterocycl*) and(peptid*) and (HIV OR AIDS or retroviral or anti*retroviral* or immunodefic*))) ANDDP>=(20050101);CTB=((protease ADJ inhibitor*) and (carbamoyl* or carbamate or urea) and (AIDS or HIV oranti?retro?viral)) AND DP>=(20050101);CL=((protease ADJ inhibitor*) and (carbamoyl* or carbamate or urea) and (AIDS or HIV oranti?retro?viral)) AND DP>=(20050101);ALL=((retroviral* ADJ protease ADJ inhibitor*) and (peptid*) and (thiazol*)) ANDDP>=(20050101);CL=((retroviral* ADJ protease ADJ inhibitor*) and (peptid*) and (thiazol*) and (carbamate* orurea* or carbamoty*)) AND DP>=(20050101);CL=((retroviral* ADJ protease ADJ inhibitor*) and (peptid*) and (thiazol*) and (polymorph*))AND DP>=(20050101);CTB=(((155213-67-5) OR (C37-H48-N6-O5-S2) OR (Kaletra) OR (Ritonavir) OR (A-84538) OR (Abbott ADJ "84538") OR (ABT-538) OR (DRG-0244) OR (HSDB ADJ"7160") OR (Norvir) OR (TMC ADJ 114r) OR (UNII-O3J8G9O825))) ANDDP>=(20050101);CL=(((155213-67-5) OR (C37-H48-N6-O5-S2) OR (Kaletra) OR (Ritonavir) OR (A-84538) OR (Abbott ADJ "84538") OR (ABT-538) OR (DRG-0244) OR (HSDB ADJ"7160") OR (Norvir) OR (TMC ADJ 114r) OR (UNII-O3J8G9O825))) ANDDP>=(20050101);CL=(((155213-67-5) OR (C37-H48-N6-O5-S2) OR (Kaletra) OR (Ritonavir) OR (A-84538) OR (Abbott ADJ "84538") OR (ABT-538) OR (DRG-0244) OR (HSDB ADJ"7160") OR (Norvir) OR (TMC ADJ 114r) OR (UNII-O3J8G9O825)) and (solution* orliquid or solvent* or suspen* or dispers*)) AND DP>=(20050101);CL=(((155213-67-5) OR (C37-H48-N6-O5-S2) OR (Kaletra) OR (Ritonavir) OR (A-84538) OR (Abbott ADJ "84538") OR (ABT-538) OR (DRG-0244) OR (HSDB ADJ"7160") OR (Norvir) OR (TMC ADJ 114r) OR (UNII-O3J8G9O825)) and (heat* orthermal*) and (stabil* or stabl*)) AND DP>=(20050101);CL=(((155213-67-5) OR (C37-H48-N6-O5-S2) OR (Kaletra) OR (Ritonavir) OR (A-84538) OR (Abbott ADJ "84538") OR (ABT-538) OR (DRG-0244) OR (HSDB ADJ"7160") OR (Norvir) OR (TMC ADJ 114r) OR (UNII-O3J8G9O825)) and (HIV ORAIDS or retroviral or anti*retroviral* or immunodefic*) and (protease ADJ inhibitor*))AND DP>=(20050101);CL=(((155213-67-5) OR (C37-H48-N6-O5-S2) OR (Kaletra) OR (Ritonavir) OR (A-84538) OR (Abbott ADJ "84538") OR (ABT-538) OR (DRG-0244) OR (HSDB ADJResults8141311017330021916200127412173581649838
"7160") OR (Norvir) OR (TMC ADJ 114r) OR (UNII-O3J8G9O825)) and ((improv* orenhanc* or increas*) near10 (absorp* or absorb* or bioavailab*))) ANDDP>=(20050101);CL=(((155213-67-5) OR (C37-H48-N6-O5-S2) OR (Kaletra) OR (Ritonavir) OR (A-84538) OR (Abbott ADJ "84538") OR (ABT-538) OR (DRG-0244) OR (HSDB ADJ"7160") OR (Norvir) OR (TMC ADJ 114r) OR (UNII-O3J8G9O825)) and (aqueous orgel* or solution* or liquid*)) AND DP>=(20050101);CL=(((155213-67-5) OR (C37-H48-N6-O5-S2) OR (Kaletra) OR (Ritonavir) OR (A-84538) OR (Abbott ADJ "84538") OR (ABT-538) OR (DRG-0244) OR (HSDB ADJ"7160") OR (Norvir) OR (TMC ADJ 114r) OR (UNII-O3J8G9O825)) and (aqueous orgel* or solution* or liquid*) and (stabl* or stabil*)) AND DP>=(20050101);CL=(((155213-67-5) OR (C37-H48-N6-O5-S2) OR (Kaletra) OR (Ritonavir) OR (A-84538) OR (Abbott ADJ "84538") OR (ABT-538) OR (DRG-0244) OR (HSDB ADJ"7160") OR (Norvir) OR (TMC ADJ 114r) OR (UNII-O3J8G9O825)) and (transdermal*or mucos* or vagin*)) AND DP>=(20050101);CL=(((155213-67-5) OR (C37-H48-N6-O5-S2) OR (Kaletra) OR (Ritonavir) OR (A-84538) OR (Abbott ADJ "84538") OR (ABT-538) OR (DRG-0244) OR (HSDB ADJ"7160") OR (Norvir) OR (TMC ADJ 114r) OR (UNII-O3J8G9O825)) and (emulsion*or cream* or liposom*)) AND DP>=(20050101);3447213187
Page 1 and 2:
Patent Lan
Page 3:
Patent Lan
Page 6 and 7:
STN- Transcript of Search History .
Page 8 and 9:
priority to an earlier Italian pate
Page 10 and 11:
Section 2 - Search Process2.1 Intro
Page 12 and 13:
these documents differed from WO199
Page 14 and 15:
prevented along with compound names
Page 16 and 17:
Section 3 - Statistical Analysis3.1
Page 18 and 19:
Figure 2 shows that the overall pat
Page 20 and 21:
Figures 4 and 5 show the most commo
Page 22 and 23:
Figure 6 illustrates the percentage
Page 24 and 25:
Figure 8 shows the distribution of
Page 26 and 27:
Patent AuthorityNu
Page 28 and 29:
Figure 11a: Geographic distribution
Page 30 and 31:
PatentAuthorityNum
Page 32 and 33:
Figure 14 shows the most common inv
Page 34 and 35:
Intellixir was used in concert with
Page 36 and 37:
4.1.2 Brief description of innovati
Page 38 and 39:
The fourth innovation track focuses
Page 40 and 41:
portant because of the thermal inst
Page 42 and 43:
4.2.2 Innovation track 2: Synthesis
Page 44 and 45:
the Synthesis of Ritonavir Innovati
Page 46 and 47:
several different ways. This partic
Page 48 and 49: 4.2.4 Innovation track 4: Solid Dos
Page 50 and 51: The broad independent claim languag
Page 52 and 53: are cited by more than one other do
Page 54 and 55: US6765019 cites WO9404193 (describe
Page 56 and 57: WO9933815. Also, the ‘869 documen
Page 58 and 59: Section 5 - Report
Page 60 and 61: AppendicesAppendix 1 - Innovation T
Page 62 and 63: 1.3 Polymorphs
Page 64 and 65: 1.5 Prodrugs of RitonavirInnovation
Page 66 and 67: ECLA Classification System: ECLA st
Page 68 and 69: Appendix 3 - Ritonavir Pate
Page 70 and 71: US4725583 OR US4725584 OR US4826815
Page 76 and 77: "HOFFMANN_LA_ROCHE_F_AND_CO_A_G" OR
Page 78 and 79: "A61K9/50" OR "A61K9/52" OR "A61K9/
Page 80 and 81: WO08051039 OR US2006205697 OR WO050
Page 82 and 83: WO09045975 OR US2009226431 OR WO071
Page 84 and 85: WO08141227 OR WO08098789 OR WO09047
Page 86 and 87: US7754718 OR WO10077317 OR US201017
Page 90 and 91: US2006099170 OR EP1219605 OR CN1768
Page 92 and 93: OR US7632853 OR WO9746222 OR US7364
Page 94 and 95: 161 PN=(WO2007071055 OR US5747490 o
Page 96 and 97: Total PatentAuthor
Page 100 and 101: STN- Transcript of Search History=>
Page 102 and 103: => s l3S L3 SSS SAM FILE=REGISTRYSA
Page 105: For more information contact WIPO a
show all

Patent Landscape Report on Ritonavir - WIPO

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?